Nelesh Govender (also @neleshg.bsky.social) (@neleshg) 's Twitter Profile
Nelesh Govender (also @neleshg.bsky.social)

@neleshg

I study fungal diseases. Prof @witshealthfac. NIHR Research Prof. Hon Prof @MRCcmm @StGeorgesUni @UCTHealthSci. Sabbatical @nicd_sa. MD, micro, epi 🌈

ID: 42234603

linkhttps://witsmycology.co.za/ calendar_today24-05-2009 16:12:37

2,2K Tweet

1,1K Followers

275 Following

Paul Sax (@paulsaxmd) 's Twitter Profile Photo

I know you’ve all been on tenterhooks, awaiting the dramatic conclusion to “How PCP Became PJP”. Well here it is. You’ll laugh! You’ll cry! And you’ll finish reading it so much better informed about this critical debate. NEJM Journal Watch NEJM blogs.jwatch.org/hiv-id-observa…

NIHR Global Health (@nihrglobal) 's Twitter Profile Photo

Professor Nelesh Govender (also @neleshg.bsky.social) tells researchers considering applying to the NIHR #GlobalHealthResearchProfessorship: 1️⃣Do it, it can be transformational! 2️⃣Apply at the right time in your career 3️⃣LMIC applicants should brief their institutions carefully More info: nihr.ac.uk/funding/global…

Graeme Meintjes (@graemein) 's Twitter Profile Photo

Highlighting the crisis posed by reduced access to CD4 testing platforms in settings where they are most needed - and the implications of this for the care of people living with HIV: thelancet.com/journals/langl…

Nelesh Govender (also @neleshg.bsky.social) (@neleshg) 's Twitter Profile Photo

Online registrations open for KLEBS2024, Nov 20-22 1st ever Klebsiella conference - latest knowledge on its epidemiology, ecology, genomics, pathogenicity, infection models, vaccines and therapeutics Online registration free to LMIC attendees. Visit klebs-2024.conferences-pasteur.org

NIHR Global Health (@nihrglobal) 's Twitter Profile Photo

Following his NIHR Global Health Research Professorship Nelesh Govender (also @neleshg.bsky.social) has received more of funding, including an impressive $1.7 million from the Gates Foundation. Prof Govender discusses how his professorship has impacted his career and his research on advanced HIV disease⤵️

Linda-Gail Bekker (@lindagailbekker) 's Twitter Profile Photo

We have been here before - once again we cannot allow political power, greed or false ideology to undermine our ability to provide care, health, and protection to the most underserved, the vulnerable and those most in need. #HIV #pepfar

EFFECT Trial (@effecttrial) 's Twitter Profile Photo

We are thrilled to share that we are down to double digits! 99 participants left to reach out recruitment target of 600. Looking forward to contributing meaningful data to help to #EndCryptoDeaths 🦠🏥💯 Nelesh Govender (also @neleshg.bsky.social) Sile Molloy Joe Jarvis Kyla Murphy

We are thrilled to share that we are down to double digits! 99 participants left to reach out recruitment target of 600. Looking forward to contributing meaningful data to help to #EndCryptoDeaths 🦠🏥💯
<a href="/neleshg/">Nelesh Govender (also @neleshg.bsky.social)</a> <a href="/sile47742/">Sile Molloy</a> <a href="/JNJarvis76/">Joe Jarvis</a> <a href="/KylaMurphyZA/">Kyla Murphy</a>
The Lancet (@thelancet) 's Twitter Profile Photo

The evidence on infection outcomes of hospital-initiated kangaroo care is unclear. In a new study, authors evaluate the role of hospital-initiated kangaroo care in preventing mortality, sepsis, & invasive infection in low-birthweight infants: hubs.li/Q03pGDGn0

The evidence on infection outcomes of hospital-initiated kangaroo care is unclear.

In a new study, authors evaluate the role of hospital-initiated kangaroo care in preventing mortality, sepsis, &amp; invasive infection in low-birthweight infants: hubs.li/Q03pGDGn0
NEJM (@nejm) 's Twitter Profile Photo

Perspective by George R. Thompson III, MD (George Thompson), and Angel N. Desai, MD, MPH: Addressing Antifungal Drug Resistance — A “One Health–One World” Challenge nej.md/4kMyVOd #GlobalHealth

Perspective by George R. Thompson III, MD (<a href="/GRThompsonMD/">George Thompson</a>), and Angel N. Desai, MD, MPH: Addressing Antifungal Drug Resistance — A “One Health–One World” Challenge nej.md/4kMyVOd 

#GlobalHealth
Open Forum Infectious Diseases (@ofidjournal) 's Twitter Profile Photo

The burden of Neonatal Invasive Candidiasis in Low- and Middle-Income Countries: a systematic review and meta-analysis. ✅ Just Accepted 🔗 bit.ly/3ZXqy9N

The burden of Neonatal Invasive Candidiasis in Low- and Middle-Income Countries: a systematic review and meta-analysis.

✅ Just Accepted
🔗 bit.ly/3ZXqy9N
Martin Hoenigl🇺🇦🇦🇹 (@martinhoenigl) 's Twitter Profile Photo

🔥🗞️Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study. Groundbreaking work on a very promising new antifungal. Free access here: authors.elsevier.com/c/1lHca5E-UokK…

Nelesh Govender (also @neleshg.bsky.social) (@neleshg) 's Twitter Profile Photo

Congrats to Serisha Naicker & our 🌍CryptoADAPT team Wits University, UP, SUN, Imperial, CISM, UZ, Duke for the new Wellcome grant Excited to dig into the environmental diversity of Cryptococcus in Africa wits.ac.za/news/latest-ne…

Meg Doherty (@mdoherty_hiv) 's Twitter Profile Photo

WHO celebrates this step to really get on track to end AIDS by 2030!Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low- and Middle-Income Countries - News Releases - The Global Fund to Fight AIDS, Tuberculosis and Malaria theglobalfund.org/en/news/2025/2…

Jacquomo (@jacquesmeis) 's Twitter Profile Photo

How to interpret MICs of amphotericin B, echinocandins and flucytosine against Candida auris (Candidozyma auris) according to the newly established EUCAST breakpoints - Clinical Microbiology and Infection clinicalmicrobiologyandinfection.com/article/S1198-…